TY - JOUR
T1 - Immediate Complications and Flow Volume Changes During Treatment Phases of Bronchial Thermoplasty: A Single-Center Descriptive Study
AU - Vijayan, Karthik
AU - Karakattu, Sajin M.
AU - Bansal, Apurva
AU - Thomas, Akesh
AU - Alazzeh, Ahmad
AU - El Minaoui, Wael
AU - Maisonet, Mildred
PY - 2021/1/1
Y1 - 2021/1/1
N2 - Introduction: Bronchial thermoplasty (B.T.) is a therapeutic bronchoscopic procedure in which controlled thermal energy is applied to the airway wall to decrease smooth muscle mass. Immediate complications of B.T. include acute exacerbation of bronchial asthma, upper and lower respiratory tract infection, hemoptysis, among others. Our study assessed these immediate adverse events and the changes in forced expiratory volume in one second (FEV1%) measured four hours after each procedure from baseline. The study also aimed to examine the number of activations during each cycle of treatment and its correlation to the corresponding change in FEV1% from baseline. Methods: A case-series analysis of 17 patients who underwent B.T. between 2014 and 2019 was done. Demographic, clinical characteristics, including pre and post-BT FEV1% measures, and the number of activations were obtained. Results: Acute exacerbation of asthma was the commonest complication accounting for 33%, 57%, and 75% after BT1, BT2, and BT3, respectively. There was deterioration in FEV1% after each treatment phase, the most significant being in BT3. There was no correlation between the number of heat activations with the change in FEV1% from baseline. Conclusion: The number of activations in B.T. does not correlate with the immediate deterioration in FEV1%, although exacerbation of asthma is the commonest complication post-B.T.
AB - Introduction: Bronchial thermoplasty (B.T.) is a therapeutic bronchoscopic procedure in which controlled thermal energy is applied to the airway wall to decrease smooth muscle mass. Immediate complications of B.T. include acute exacerbation of bronchial asthma, upper and lower respiratory tract infection, hemoptysis, among others. Our study assessed these immediate adverse events and the changes in forced expiratory volume in one second (FEV1%) measured four hours after each procedure from baseline. The study also aimed to examine the number of activations during each cycle of treatment and its correlation to the corresponding change in FEV1% from baseline. Methods: A case-series analysis of 17 patients who underwent B.T. between 2014 and 2019 was done. Demographic, clinical characteristics, including pre and post-BT FEV1% measures, and the number of activations were obtained. Results: Acute exacerbation of asthma was the commonest complication accounting for 33%, 57%, and 75% after BT1, BT2, and BT3, respectively. There was deterioration in FEV1% after each treatment phase, the most significant being in BT3. There was no correlation between the number of heat activations with the change in FEV1% from baseline. Conclusion: The number of activations in B.T. does not correlate with the immediate deterioration in FEV1%, although exacerbation of asthma is the commonest complication post-B.T.
KW - Bronchial thermoplasty
KW - bronchial asthma
KW - forced expiratory volume in one second (FEV1%)
KW - procedure-related complications
UR - https://dc.etsu.edu/etsu-works/9730
UR - https://doi.org/10.1080/02770903.2021.1924775
U2 - 10.1080/02770903.2021.1924775
DO - 10.1080/02770903.2021.1924775
M3 - Article
JO - Journal of Asthma
JF - Journal of Asthma
ER -